Background/Aim: Previous studies have shown that fibroblast growth factors (FGFs) are involved in the process of liver injury repair. Liver regeneration after partial hepatectomy (PH) is impaired in transgenic mice expressing dominant-negative FGFR2b in hepatocytes. Although FGF7, a ligand specifically bound to FGFR2b, is expressed by activated hepatic stellate cells (HSCs) in fibrotic livers, the expressions and functions of FGF7 and FGFR2b after PH remain unexplored. Therefore, this study sought to examine the potential role of FGF7 signaling during liver regeneration. Methods: We examined the expression of FGF7 and FGFR2b in normal and regenerating livers. Effects of FGF7 on hepatocytes were examined in vitro using primary hepatocyte culture with FGF7 recombinant protein and in vivo by hydrodynamicbased gene transfer method. Results: We found that FGF7 expression was increased according to the activation status of HSCs after PH. The receptor, FGFR2b, was also increased in hepatocytes during liver regeneration. In vitro treatment with FGF7 protein activated ERK1/2 and promoted proliferation of hepatocytes isolated from regenerating livers. In vivo overexpression of exogenous FGF7 could notably promote hepatic proliferation and activate MAPKs after PH. Conclusion: This study suggests a role for activated HSC-expressed FGF7 in stimulating FGF signaling pathways in hepatocytes and regulating liver regeneration.
Introduction
The fibroblast growth factor (FGF) family is composed of 22 members, and FGF receptors (FGFR1-FGFR4) mediate their biological activities [1, 2] . Alternative splicing in these receptors' extracellular domain generates additional isoform diversity, providing different ligand-binding specificities. The best understood signaling molecules induced by FGFs are MAPKs, AKT, and PLC [3] . The signaling pathways of FGF are involved in the developing liver. For example, livers in Fgfr2b knockout mouse embryos are smaller than those in wild type littermates [4] . Several FGFR2b ligands are implicated in developing livers, including FGF1, FGF7, and FGF10. In vitro studies have shown that FGF1 enriches bipotential hepatic progenitor cells, whereas FGF7 promotes differentiation of biliary epithelial cells (BECs) in cultured embryonic livers [5, 6] . Expression of FGF10 in hepatic stellate cells (HSCs) is crucial for the developing liver by maintaining survival of hepatoblasts through FGFR2b receptor [4] .
Previous studies have identified FGF signaling in both liver repair and regeneration. Expression of FGF1 occurs in both hepatocytes and non-parenchymal cells (NPCs) after partial hepatectomy (PH) [7] . However, Fgf1/Fgf2 double knockout mice show normal liver regeneration [8] . Therefore, FGF1 may not have an essential role in liver mass restoration. Increased expression of FGF9 in activated HSCs provides a mitogenic signal to hepatocytes in the liver, which is insulted by CCl 4 [9] . Expression of FGF21 is up-regulated in hepatocytes during liver regeneration after PH or CCl 4 administration, but overexpression of FGF21 does not affect compensatory growth after either treatment [10] . The expression level of FGFR4 is abundant in hepatocytes. Although the FGFR4 expression level after PH has not been reported, Fgfr4 knockout mice exhibit normal recovery of liver mass [11] . Therefore, FGFR4 may not be involved in the regeneration process or its function is compensated by other factors. Expression of Fgfr2 mRNA increases during liver regeneration [12] . A previous study showed that in addition to FGFR4, hepatocytes also express FGFR2b [13] . Whether or not expression of FGFR2b is increased in hepatocytes after PH is not reported. Because liver regeneration is arrested in the mouse liver expressing dominant-negative FGFR2b [14] , these results demonstrate the importance of FGFR2b signaling in liver regeneration.
Among FGFR2b ligands, FGF7 is a potent mitogen for hepatocytes in vitro that is comparable to the hepatocyte growth factor [15] . In vivo administration of FGF7 protein promotes a small level of hepatocyte proliferation [16, 17] and enhances retrovirus infection efficiency without PH [18] . Because FGF7 is expressed by activated HSC in chronic liver diseases of humans [13] , and because HSC is activated after PH [19] , we hypothesized that FGF7 may participate in the liver regeneration process.
Previous studies have indicated that FGF7 may exert mitogenic effects in hepatocytes during liver injury repair [13, 14, 20] . However, these studies have not provided in vivo evidence to study the role of FGF7 and FGFR2b signaling during liver regeneration. In this study, we analyzed the expressions of FGF7 and FGFR2b in normal and regenerating livers. Furthermore, hepatocytes and other NPCs were isolated from the liver for determining FGF7-expressing cells. Additionally, effects of FGF7 on isolated hepatocytes were analyzed. Because FGF7 is a secreted protein, overexpressing FGF7 by hydrodynamics is feasible to study its effects on hepatocytes after PH. This study shows that FGF7 is expressed in activated HSCs, while FGFR2b is up-regulated in hepatocytes after PH. Additionally, increased activation of FGF7/FGFR2b signaling pathways can promote hepatocyte proliferation during the process of liver regeneration.
Materials and Methods

Mice
Wild type FVB mice were housed according to protocols approved by the Institutional Animal Care and Use Committee of Tzu Chi University, Hualien, Taiwan.
Partial hepatectomy (PH)
Male mice at 8-9 weeks old were subjected to PH under ketamine/xylazine anesthesia (80-100 mg/kg) by intraperitoneal (i.p.) administration. About 70% of the liver including the median and left lateral lobes was removed. The remnant liver was analyzed at indicated time points after PH. Greater than 85% of mice survived after PH and no significant differences of survival rates were observed in each group.
Isolation of non-parenchymal cells and hepatic stellate cells
NPCs were prepared by the pronase/collagenase perfusion method [21] . Briefly, after perfusion in situ with Mg 2+ and Ca
2+
-free Hanks balanced salt solution (HBSS), livers were perfused with pronase E (Sigma-Aldrich, St. Louis, MO) and collagenase type IV (Sigma-Aldrich, St. Louis, MO) in HBSS. The perfused liver cells were filtered and centrifuged twice at 50g for 2 minutes to remove hepatocytes. The supernatant was further centrifuged at 500g for 7 min. The resulting pellet containing NPCs was collected for RNA extraction or resuspended in 8.7 ml of 17.5% OptiPrep (Sigma-Aldrich, St. Louis, MO), carefully layered on 2.5 ml of 11.5% OptiPrep and 1 ml of HBSS. Cells were centrifuged at 1400g for 17 min without brakes. Cells at top interface were collected as purified HSCs. The purity of HSCs was greater than 90% as identified by immunostaining using anti-desmin antibody (DakoCytomation, Glostrup, Denmark).
Isolation of hepatocytes
Primary hepatocytes were isolated from normal or regenerating livers by 2-step collagenase perfusion method. Briefly, the liver was perfused with liver perfusion medium (Invitrogen, Carlsbad, CA), followed with liver digest medium FGF7 Signaling Promotes Liver Regeneration (Invitrogen, Carlsbad, CA). Hepatocytes were isolated by carefully dissociating the liver with forceps and filtered through a 70 μm cell strainer. Hepatocytes were washed twice in cold hepatocyte wash medium (Invitrogen, Carlsbad, CA) by centrifugation at 50g for 2 minutes. Viability of the collected hepatocytes assessed by Trypan Blue exclusion exceeded 70%. Hepatocytes were plated in Williams modified Eagle's medium (Invitrogen, Carlsbad, CA) with 10% FBS, 1 μM insulin, 2 mM glutamine, and 3 μM dexamethasone. After adhering hepatocytes for 3 hours, the unattached cells were removed. To determine whether FGF7 could activate ERK1/2 in primary hepatocytes, cells were starved in Williams modified Eagle's medium (Invitrogen, Carlsbad, CA) with 2 mM glutamine, 3 μM dexamethason and 1 μg/mL heparin for 48 hours. Subsequently, 50 ng/ml of FGF7 recombinant protein was added (R&D Systems, Minneapolis, MN). Cell lysates were harvested at indicated time points after FGF7 treatment.
In vitro proliferation assay
To determine whether FGF7 can promote proliferation of primary hepatocyte, cells were starved in Williams modified Eagle's medium (Invitrogen, Carlsbad, CA) with 2 mM glutamine, 3 μM dexamethason, 1.67 μM insulin and 1 μg/mL heparin for 24 hours. Subsequently, 50 ng/ml of FGF7 recombinant protein was added for another 24 hours (R&D Systems, Minneapolis, MN). Cultures were incubated with 10 μM BrdU for the final 6 hours. Cells were fixed in 4% paraformaldehyde and used for subsequent staining. Incorporated BrdU was localized using an anti-BrdU antibody (B2531, 1:100 dilution; Sigma-Aldrich, St. Louis, MO) followed by an HRP-conjugated anti-mouse antibody (1:100 dilution; R&D Systems, Minneapolis, MN) and a tyramide signal amplification substrate reagent linked with FITC (TSA-FITC) (Perkin Elmer, Waltham, MA). The cells were mounted with SlowFade Gold antifade reagent with DAPI (Invitrogen, Carlsbad, CA).
Immunofluorescence
Primary NPCs or HSCs perfused from either normal or regenerating livers at indicated time points were seeded on chamber slides. These cells were washed, fixed and permeabilized. Incubation with anti-desmin antibody (M0760, 1:1000 dilution; DakoCytomation, Glostrup, Denmark) at 4°C overnight was followed by a HRP-conjugated secondary antimouse antibody (1:100 dilution; R&D Systems, Minneapolis, MN). TSA-FITC (Perkin Elmer, Waltham, MA) was added as substrate. After blocking the peroxidase activity of secondary antibody, anti-FGF7 antibody (sc-7882, 1:200 dilution; Santa Cruz Biotechnology, Santa Cruz, CA) was added at 4°C overnight. HRP-conjugated secondary anti-rabbit antibody (1:100 dilution; R&D Systems, Minneapolis, MN) and TSA-TMR substrates (Perkin Elmer, Waltham, MA) were applied. The cells were mounted with SlowFade Gold antifade reagent with DAPI (Invitrogen, Carlsbad, CA).
RT-PCR and quantitative RT-PCR
Total RNA was extracted from liver tissues or isolated primary cells by using TRIZOL reagent (Invitrogen, Carlsbad, CA). Reverse transcribed the RNA by ImpromII RT kit (Promega, 
Immunoprecipitation
Harvested livers or isolated HSCs were lysed in RIPA with protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO). Total protein concentrations were determined by Bradford protein assay (Bio-Rad, Hercules, CA). Equal amounts of total protein for each sample lysate (500 μg for liver tissues and 250 μg for HSCs) were used. Anti-FGF7 antibody (AF-251-NA, R&D Systems, Minneapolis, MN) and anti-HA antibody (sc-805, Santa Cruz Biotechnology, Santa Cruz, CA) were used for detecting the expression of endogenous and exogenous FGF7, respectively. Primary antibody was added to the protein lysates at 4°C for 2 hours with gentle shake. Protein G agarose beads (Santa Cruz Biotechnology, Santa Cruz, CA) were then added to the premixed solution and incubated at 4°C for 16 hours with gentle shake. Immunoprecipitants were washed for four times with buffer and analyzed by Western blot.
Western blotting
Anti-FGF7 antibody (AF-251-NA, 1:1000 dilution; R&D Systems, Minneapolis, MN) was used for detecting FGF7 expression in the livers and HSCs. Antibodies against signaling molecules including ERK1/2 (#9102), phospho-ERK1/2 (#9101), P38 (#9212), phospho-P38 (#9211), AKT (#9272) and phospho-AKT (#9270) were purchased from Cell Signaling Technology (Danvers, MA). Anti-phosphotyrosine 196 FRS2 antibody (#3864, 1:500 dilution; Cell Signaling Technology, Danvers, MA) was used to detect the activation of FGF signaling. Anti--actin antibody (MAB1501, 1:5000 dilution; Merck Millipore, Billerica, MA.) was used for the internal control. Goat, mouse or rabbit secondary antibody conjugated with HRP (1:1000 dilution; R&D Systems, Minneapolis, MN) was applied. The chemiluminescent signals were visualized by Immobilon HRP substrate kit (Millipore, Billerica, MA) and captured by the BioSpectrumAC Imaging System (UVP, Upland, CA). Band intensity was quantified by UVP Visionworks LS software.
Immunohistochemistry
Five-micrometer thick paraffin-embedded sections were prepared for immunohistochemical staining. Sections were Cell Physiol Biochem 2011;27:641-652 incubated with primary antibody against FGFR2 (sc-122, 1:50 dilution; Santa Cruz Biotechnology, Santa Cruz, CA). Histofine Simple Stain Max PO kit (Nichirei Biosciiences, Tokyo, Japan) was used for detecting FGFR2 signals. For analyzing cells at S phase of cell cycle, mice were i.p. injected with BrdU (GE Healthcare, Buckinghamshire, United Kingdom) 2 hours before being sacrificed. Cell Proliferation kit (GE Healthcare, Buckinghamshire, United Kingdom) was used according to manufacturer's instruction. Anti-PCNA antibody (sc-56, 1:200 dilution; Santa Cruz Biotechnology, Santa Cruz, CA) was also used to detect proliferating cells. After incubation with biotinconjugated anti-mouse antibodies, the positive cells were detected by using Vectastain Elite ABC kit (Vector Labs, Burlingame, CA). Signals were visualized by using DAB substrate kit (Vector Labs, Burlingame, CA). Counterstain was made by hematoxylin. The percentage of hepatic BrdU-or PCNA-positive cells was determined by examination of at least three different random 400X fields per mouse. At least 3 mice per group at each time point were analyzed. The results were presented as the mean ± standard deviation (SD). Statistical significance was determined by two-tailed Students t test, with a P value < 0.05 considered significant.
Hydrodynamics-based gene delivery
In order to overexpress FGF7 specifically in mouse livers, 7 to 8 weeks old FVB mice were hydrodynamic-injected via tail vein [22] . The control pCG empty plasmid and the pCG-FGF7-HA plasmid were used in this study. The pCG-FGF7-HA plasmid encoded FGF7 protein fused with HA-tag was driven by cytomegalovirus (CMV) promoter. Plasmid DNA was prepared by using Endofree plasmid maxiprep kit (Qiagen, Valencia, CA) to minimize contamination of endotoxin. Twenty micrograms of plasmid DNA in 0.9% NaCl solution was injected through tail vein smoothly in 5 seconds. For analyzing exogenous FGF7 expression, livers were harvested 1 or 7 days after hydrodynamic injection (H1D or H7D). Mice were subjected to PH seven days after hydrodynamic injection.
Results
FGF7 expression in regenerating livers
Previous studies have shown that FGF7 is a mitogenic growth factor for hepatocytes [15, 18] . To gain insight into the possible role of FGF7 in liver regeneration, we first analyzed its expression in regenerating livers after PH. Levels of Fgf7 mRNA were detectable in normal livers and increased in regenerating livers as analyzed by RT-PCR (Fig. 1A) . Using real-time RT-PCR for quantification, regenerating livers harvested at 48 hours after PH (PH48h) revealed a 3-fold higher Fgf7 mRNA level than that of normal livers (PH0h) (Fig. 1B) . IPWestern blot analyses of FGF7 protein expression in liver lysates prepared from normal and regenerative livers showed a similar result (Fig. 1C) . Quantification of the obtained bands revealed a 1.5-fold increase of FGF7 protein at PH72h and then decreased to a level Fgf7. Among NPCs, activated HSCs have been identified as the cellular source of FGF7 in chronic liver disease, such as liver fibrosis [13] . To verify that HSCs also express FGF7 during liver regeneration, immunofluorescence analysis of FGF7 coupled with desmin, a marker of HSCs, was performed in NPCs. We determined that FGF7 was detected only in desmin-positive NPCs from both normal and regenerating livers (Fig. 1E ). According to these results, we suggest that FGF7 is produced by HSCs. Because HSCs are activated not only in fibrotic livers but also in PH-induced regenerating livers [13, 19] , we sought to determine whether activation of HSC in regenerating liver results in more FGF7 production. Low Fgf7 mRNA expression was detected in HSCs isolated from normal livers. Levels of Fgf7 mRNA in HSCs increased at PH24h and peaked at PH72h. The expression level of Fgf7 decreased at PH120h (Fig. 2A) . Additionally, the expression of Sma in HSCs was paralleled with Fgf7 at each time point examined ( Fig.  2A) . Real time RT-PCR analysis revealed that Fgf7 expression was 3.3-fold higher in HSCs isolated from PH72h regenerating livers compared to those from normal livers (Fig. 2B) . These results indicate that the activation of HSCs in regenerating livers may be responsible for the increased expression of Fgf7. We further analyzed FGF7 protein expression in isolated HSCs by IP- Western   Fig. 4 . FGF7 activates downstream FGF signaling and promotes proliferation of primary hepatocytes. Primary hepatocytes from normal (nL) and regenerating livers (PH24h, PH48h, PH72h and PH120h) were serum starved, treated with 50 ng/ml FGF7, harvested at indicated time points and analyzed for the phosphorylation of (A) FRS2 and (B) downstream signaling mediators including ERK1/2 and P38. -actin was used as an internal control. (C) The ratios of phosphorylated ERK1/2 to total ERK1/2 were analyzed (n=3 at each time point) and data were expressed as relative fold-induction of FGF7-stimulated hepatocytes compared to control hepatocytes (mean +/-SD). *, P<0.05 and **, P<0.01. (D) Immunofluorescence of BrdU (green) in hepatocytes isolated from normal (nL) and PH72h livers. Hepatocytes were pulselabeled with BrdU for 6 hours. Cells grown in basal medium without FGF7 were used as controls. (E) Percentages of BrdU-positive hepatic nuclei of FGF7-treated cells were quantified and compared to control cells (n=5 for each group). * P < 0.05 and ** P < 0.01.
Fig. 5.
Exogenous FGF7 is overexpressed in the liver after hydrodynamic injection and PH. FGF7-injected mouse livers were harvested at one day and seven days after injection (H1D and H7D), respectively. PH was performed at H7D and regenerating FGF7-injected livers were harvested at 6, 12 and 24 hours after PH (H/PH6h, 12h and 24h). blot analysis. Results showed that FGF7 protein in HSCs isolated from normal livers was low and increased in HSCs isolated from PH72h livers (Fig. 2C) . Quantification of the obtained bands revealed a 1.5-fold increase of FGF7 protein at PH72h and then decreased to a level comparable to normal livers at PH120h (Fig. 2D) . Immunofluorescence staining of FGF7 and desmin also showed strong FGF7 signal intensity in HSCs isolated from PH72h regenerating livers (Fig. 2E) . Therefore, HSCs express FGF7 in normal livers, and activated HSCs produce an increased FGF7 expression during liver regeneration.
FGFR2b expression in normal and regenerating livers
We next analyzed the hepatic expression of the FGF7 receptor, FGFR2b, during the process of liver regeneration. Levels of Fgfr2b mRNA were low in normal livers and increased in regenerating livers (Fig.  3A) . Using real-time RT-PCR, regenerating livers harvested at PH24h revealed a 3-fold higher Fgfr2b mRNA level than that of normal livers (PH0h) (Fig. 3B) . Immunohistochemical staining revealed that expression of FGFR2 increased gradually after PH. Strong staining of FGFR2 in the hepatocytes was detected especially at PH72h (Fig. 3C) . A decreased FGFR2 signal was observed at PH120h and thereafter (Fig. 3C and data not shown). Because the anti-FGFR2 antibody we used could also detect FGFR2c, a reported FGF receptor expressed in HSCs [9] , the expression level of Fgfr2c mRNA during liver regeneration was also examined. Similar to Fgfr2b, the expression of Fgfr2c increased after PH, and revealed a 4-fold higher expression level at PH48h compared to normal livers (PH0h) (Fig. 3A  and 3B ). These results indicate that both isoforms of FGFR2 increase after PH. Additionally, we suggest the increased level of FGFR2b in hepatocytes may be crucial for responding to FGF7 in regenerating livers.
Increased activation of FRS2 and ERK1/2 by FGF7 in hepatocytes from regenerating livers
Previous research has reported that fibroblast growth factor receptor substrate 2 (FRS2 ) functions as a major mediator downstream from the FGF receptors [23] . To confirm that the increased FGFR2b in hepatocytes can be activated by FGF7 during liver regeneration, phosphorylation of FRS2 was examined. Hepatocytes were isolated from normal and regenerating livers, serum starved, and treated with FGF7 recombinant protein. We discovered that FGF7 induced the phosphorylation of A total of 500 nuclei were scored per section at a magnification of 400X. * P < 0.05 and ** P < 0.01.
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Cell Physiol Biochem 2011;27:641-652 FRS2 at tyrosine 196 (Fig. 4A ), serving as a docking site for direct binding of the GRB2-SOS complex. We sought to determine whether or not the activity of FGF downstream signaling in hepatocytes from regenerating livers, which express more FGFR2b, is higher after FGF7 treatment. Because the extracellularregulated kinases (ERK1 and ERK2, also known as P44/ P42 MAPKs) are the key effectors in the signal transduction of FGF and ERK1/2 [1] and have also been identified to be crucial for FGF7-induced proliferation in pancreatic cells [24] , we analyzed the activation of ERK1/ 2 in hepatocytes after stimulation with FGF7. In hepatocytes isolated from normal livers, activation of ERK1/2 was weak after addition of FGF7 and showed no difference between control cells (Fig. 4B, Lanes 1-2) . Notably, in hepatocytes isolated from livers 24, 48, and 72 hours after PH, activations of ERK1/2 were induced after FGF7 treatment (Fig. 4B, Lanes 3-8) . Although activation of ERK1/2 induced after FGF7 treatment in hepatocytes isolated at PH120h (Fig. 4B , Lanes 9-10), the activation level was lower than those observed at PH24h to PH72h. After quantification, we discovered that FGF7 induced a 2.3-fold increase of ERK1/2 activation levels in hepatocytes isolated from PH48h regenerating livers (Fig. 4C) . In addition to ERK1/ 2, slightly increased phosphorylation of P38 by FGF7 was Fig. 7 . FGF7 overexpression increases hepatic PCNA expression after PH. Regenerating livers were harvested from (A-C) control and (D-F) FGF7-injected mice (H/PH6h, H/PH12h and H/PH24h) and stained for PCNA. Counterstaining was performed with hematoxylin. Scale bar: 100 μm. (G) Quantified ratios of PCNApositive hepatic nuclei in FGF7-overexpressing livers were compared to pCG control livers (n=3 for each group). A total of 500 nuclei were scored per section at a magnification of 400X. ** P < 0.01. detected at PH24h (Fig. 4B, Lanes 3-4) ; activations of JNK and AKT were not induced by FGF7 at each time point examined (data not shown). These results indicate that FGF7 activates ERK1/2 downstream from FGF signaling in hepatocytes isolated from regenerating livers.
Increased mitogenic response in primary hepatocytes from regenerating livers
We next studied the effects of FGF7 on DNA synthesis of primary hepatocytes. FGF7 is a mitogenic factor for primary hepatocytes from normal livers of rats [15] . We examined whether or not FGF7 could promote proliferation of primary hepatocytes from regenerating livers. Serum-starved hepatocytes from normal or PH72h regenerating livers were stimulated with FGF7 and pulselabeled with BrdU. BrdU-incorporation in primary hepatocytes treated with FGF7 was increased compared to control cells grown in the basal medium (Fig. 4D) , suggesting that FGF7 is a mitogen for primary hepatocytes either from normal or regenerating livers. Notably, after FGF7 treatment, the percentage of proliferating hepatocytes from PH72h livers was 2.2-fold higher than that of cells from normal livers (Fig. 4E) . According to these results, we suggest that increased expression of FGFR2b during liver regeneration could facilitate FGF7-induced proliferation of hepatocytes. Fig. 8 . FGF7 overexpression activates MAPKs after PH. Livers from pCG control and FGF7-overexpressing livers were collected at 6, 12 and 24 hours after PH (H/PH6h, 12h and 24h). (A) Antibodies against total and phosphorylated ERK1/2 and P38 were used for Western blot analyses.
-actin was used as an internal control. (B) The ratios of phosphorylated ERK1/2 to total ERK1/2 were analyzed (n=3 at each time point) and data were expressed as relative fold-induction of FGF7-overexpressed mouse livers compared to pCG controls (mean +/-SD). *, P<0.05.
Efficient delivery of FGF7 to the liver by hydrodynamics
To evaluate the role of FGF7 in liver regeneration, we used hydrodynamics to overexpress FGF7 in the liver. This hydrodynamic-based approach can deliver genes efficiently to the liver and has been applied to study liver regeneration [25, 26] . The control vector (pCG) or FGF7-expressing vector (pCG-FGF7-HA) was delivered to the liver and the expression of FGF7 was detected. Real-time RT-PCR showed a high mRNA expression level of Fgf7 one day after hydrodynamic injection (H1D) (Fig. 5A) . Liver lysates immunoprecipitated with an anti-HA antibody were detected by Western blot analysis with an anti-FGF7 antibody. Protein of FGF7 was expressed at H1D (Fig. 5B) . These results indicate a successful delivery and expression of exogenous FGF7 genes to the liver. Because a previous study showed that hydrodynamic injection causes transient liver injury and then recovers to normal within 1 week [27] , PH was performed at 7 days after hydrodynamic injection (H7D). Although the mRNA and protein expression l evels of exogenous FGF7 at H7D were not as high as H1D, the expression of exogenous FGF7 was still transiently increased, especially from PH6h to PH12h (Fig. 5A and 5B). These results show that expression of exogenous FGF7 increases after PH during liver regeneration.
Advanced DNA synthesis after PH in FGF7-overexpressing livers
To determine whether or not overexpressed FGF7 promotes liver regeneration, cell proliferation was analyzed by BrdU incorporation assay. Only few BrdU-positive hepatocytes were detected in wild type (WT) normal livers, control-injected livers, and FGF7-overexpressed livers at H7D (Fig. 6A, E and I ). At PH24h, WT and controlinjected livers exhibited low BrdU-incorporation ratios (0.16 ± 0.25 % in WT; 5.55 ± 5.84 % in control) (Fig. 6B , F and M). By contrast, a high percentage of BrdU-positive hepatocytes (33.24 ± 7.85 %) was detected as early as 24 hours after PH in FGF7-overexpressing livers ( Fig. 6J  and 6M ). In the WT and control mice, BrdU-positive hepatocytes were increased at PH48h (Fig. 6C and 6G) . The ratios of BrdU-positive hepatocytes in FGF7-overexpressed livers were even greater than those of WT and control livers at this time point (Fig. 6K and 6M) . Although all three groups exhibited decreased ratios of BrdU-positive hepatocytes at 72 hours after PH, the ratio was still higher in FGF7-overexpressing livers than in WT and controls (Fig. 6D, H , L, and M). These results suggest that high-level expression of FGF7 can advance the progression of hepatocyte DNA synthesis.
Proliferating cell nuclear antigen (PCNA) has been used as a marker of G0/G1 transition after PH [28] . To confirm that the advanced DNA replication in hepatocytes was due to earlier transition of hepatocytes from the quiescent stage into the cell cycle, we examined the expression of PCNA at 6, 12, and 24 hours after PH in control and FGF7-overexpressing livers. The data shows that PCNA-positive hepatocytes increased in FGF7-overexpressed mice at 6 hours (24.47 ± 12.04 % in control versus 46.91 ± 6.7 % in FGF7) and 12 hours after PH (35.08 ± 7.68 % in control versus 55.33 ± 6.19 % in FGF7) (Fig. 7A, B, D , E, and G). Twenty-four hours after PH, both control and FGF7-overexpressed livers exhibited comparable numbers of PCNA-positive hepatocytes (Fig. 7C, F and G) . Considered together, these findings indicate that overexpression of FGF7 after PH can induce cell cycle progression of hepatocytes to promote liver regeneration.
Activation of MAPKs in FGF7-overexpressing livers after PH
From our in vitro study, ERK1/2 and P38 were activated by FGF7 in hepatocytes isolated from regenerating livers (Fig. 4B and 4C ). We then analyzed the effects of FGF7 overexpression on MAPKs activation in the regenerating liver after PH. Regenerating livers were harvested from 6 to 24 hours after PH because the expression of exogenous FGF7 was highest during this period and decreased thereafter (Fig. 5) . In FGF7-overexpressing livers, the level of ERK1/2 phosphorylation was higher than that of control livers from PH6h to PH12h and decreased at PH24h (Fig. 8A and B ). The phosphorylation level of P38 also increased in FGF7-overexpressing livers (Fig. 8A) . The activation of AKT was analyzed; however, no difference was apparent in the amount of phosphorylated AKT (data not shown). According to these results, FGF7 might induce hepatocyte proliferation through the MAPK pathways during liver regeneration.
Discussion
Increased FGF7 and FGFR2b expression during liver regeneration
Inhibition of FGF signals delays liver regeneration in both mice and zebrafish, implying an essential role for this signaling pathway during regeneration [14, 29] . Initially, we discovered that Fgf7 mRNA expression was upregulated from 24h and peaked at 48h after PH. This duration corresponded with hepatic proliferation in the mouse PH model [30] , suggesting that FGF7 may play a role in the regenerating process. The observation is contrary to the previous finding that Fgf7 mRNA is not detected by RNase protection assay (RPA) either in normal livers or in regenerating livers after PH [14, 31] . Because sensitivity of RPA (about 10 5 copies of mRNA) is lower than that of RT-PCR (approximately 50 to 100 copies of mRNA) [32] , we suggested that although Fgf7 mRNA is increased during liver regeneration, its expression level maybe too low to be detected by RPA. Although increased Fgf7 expression in the spleen after PH might act as an endocrine and reach the liver through the portal circulation [31] , our study revealed that PHactivated HSC is another crucial cellular source of FGF7 in regenerating livers.
Consistent with the finding that Fgfr2 mRNA expression is increased in regenerating livers after PH [12] , we discovered that the expression of Fgfr2b is remarkably increased after PH. In vitro study revealed that higher activation levels of FRS2 , ERK1/2, and P38 can be induced after treatment with FGF7 in hepatocytes isolated from regenerating livers. Because FGF7 can specifically bind to FGFR2b [1] , which is exclusively expressed by hepatocytes in the liver [13, 31] , the activated HSC-produced FGF7 may directly activate FGFR2b on hepatocytes in regenerating livers, implying that an essential paracrine interaction between activated HSCs and hepatocytes may exist during liver regeneration.
Dynamic expression of exogenous FGF7 after hydrodynamics and PH
To assess the function of FGF7 during liver regeneration, FGF7 was ectopically expressed in hepatocytes by hydrodynamic injection. The FGF7 expression level decreased gradually after hydrodynamic injection. This transgene silencing might be the result of histone modifications that turn episomal vectors into a heterochromatin state [33] . By contrast, another study revealed that histone modification plays no role in gene silencing and the transgene expression is reactivated by a second hydrodynamic injection with saline [34] . Additionally, we discovered transiently increased expression levels of FGF7 after PH. A previous report indicated that histone acetylation precedes DNA replication after PH [35] . Furthermore, expressions of D-type cyclins and cell cycle progression of hepatocytes after toxic-induced injury require the activity of histone acetyltransferase [36] . Therefore, whether histone acetylation after PH also contributes to the dynamic expression of transgenes needs to be further examined.
Increased hepatocyte proliferation in FGF7-overexpressed livers after PH
Recently, essential cytoprotective effects of FGFR1 and FGFR2 after PH have been reported [31] . A high mortality rate has been observed at PH24h in hepatocytespecific Fgfr1/Fgfr2 knockout mice compared to controls. Further examinations have indicated that FGF signaling induces expression of detoxification-related genes immediately after PH, including Dbp and Tef. After FGF7 protein is i.p. injected, expression of these two genes is increased in control mice but not in hepatic Fgfr1/Fgfr2 knockout mice. Therefore, these findings strongly suggest that PH-activated FGF signaling in hepatocytes is crucial for detoxification during liver regeneration. Moreover, hepatocyte proliferation after PH is normal in Fgfr4 knockout mice and is enhanced in the survived hepaticspecific Fgfr2 knockout mice [11, 31] . These results are different from the inhibition study using the dnFgfr2b transgenic mouse model, in which liver regeneration is arrested in the late G1 phase of the cell cycle [14] . In contrast to the above knockout mice, transgenic mouse hepatocytes expressing dnFGFR2b inhibits all FGF signaling. These results indicate that activation of either FGFR2b or FGFR4 alone may be sufficient for normal hepatocyte proliferation.
In this study, we determined that proliferation of hepatocytes after PH was promoted after FGF7 overexpression. Because FGF7 can directly act on primary hepatocytes isolated from regenerating livers to promote their proliferation, the overexpressed FGF7 in vivo might also directly act on hepatocytes to promote proliferation during liver regeneration. However, whether or not FGF7 accelerates hepatocyte proliferation in other indirect manners must still be further examined. We also compared the survival rates after ketamine/xylazine anesthesia and PH were performed. No obvious difference of survival rate was observed in WT, pCG control or pCG-FGF7-HA-injected mice (data not shown), which might be due to the existence of endogenous FGF signaling cascades. Additionally, we discovered that the recovery of liver mass in FGF7-overexpressed mice after five days of regeneration was comparable to control mice (data not shown). This inconsistency between FGF7 in promoting hepatocyte proliferation and liver mass recovery might be because exogenous FGF7 was only transiently overexpressed in the liver after PH. Therefore, the enhanced mitogenic effect of exogenous FGF7 is correlated with its expression level during liver regeneration.
Activation of MAPKs by exogenous FGF7 in the regenerating livers
Two key effectors activated by FGFs in the signaling pathway are MAPKs and AKT [1, 3] . A previous study showed that ERK1/2 phosphorylation in the midlate G1 phase after PH is essential for G1/S phase progression [37] . In this study, we discovered that activations of ERK1/2 and P38 (but not AKT) were induced by FGF7 in hepatocytes isolated from PH48h and PH72h regenerating livers. When FGF7 was overexpressed in regenerating livers, greater activations of ERK1/2 and P38 were detected, especially from 6 to 12 hours after PH. Recently, FGF7 has been shown to promote proliferation of ductal cells through activating ERK1/2 in diabetic rats with beta-cell deficiency [24] . In hepatic Fgfr1/Fgfr2 knockout mice, the activations of ERK1/2 and P38 were strongly reduced at PH6h, indicating a defect in the priming phase and subsequent impaired activation of survival-related genes [31] . These findings suggest that FGF7-promoted hepatic proliferation during liver regeneration may be mediated by activating the MAPK signaling pathway.
Our results provide the first evidence for the increased expression of FGF7 and FGFR2b in HSCs and hepatocytes, respectively, during liver regeneration. FGF7 induces phosphorylation of MAPKs but not AKT in vitro or in vivo after PH. In addition to the cytoprotective effects of FGF7 in the priming phase, overexpression of FGF7 in the liver after PH induces hepatocyte proliferation may provide a clue for clinical application of FGF7 protein to promote liver regeneration after surgical resection.
